OncoSec Medical Inc (ONCSQ)

[guti]

I clearly said “expenses will be increased significantly on the upcoming quarterly report”, which means the $4 million referenced was only to show how the Nasdaq viewed financially the company in the past, since no one has the exact number yet. I do agree that cash in hand is a fair evaluation for a small new company with no revenue, but this is the stock market and the risk also has a price. How much is the science worth to you is my question. You might say nothing, but it should have a price, else it would not belong in the Nasdaq. Now add that to the cash at hand and you will get a real fair market cap.